Therapeutic efficacy of PUMA for malignant glioma cells regardless of p53 status

Human Gene Therapy

Volumn 16, Issue 6, 2005, Pages 685-698

  Ito, Hideaki ^a   Kanzawa, Takao ^a   Miyoshi, Toru ^b   Hirohata, Satoshi ^b   Kyo, Satoru ^c   Iwamaru, Arifumi ^a   Aoki, Hiroshi ^a   Kondo, Yasuko ^a   Kondo, Seiji ^a,d  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b OKAYAMA UNIVERSITY   (Japan)

^c KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BH3 PROTEIN; CASPASE 3; CASPASE 6; CASPASE 8; P53 UPREGULATED MODULATOR OF APOPTOSIS; PROTEIN P53; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER THERAPY; CELL DAMAGE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG INHIBITION; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; FLOW CYTOMETRY; GENE OVEREXPRESSION; GENE THERAPY; GENE TRANSFER; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MITOCHONDRION; MOUSE; NONHUMAN; UPREGULATION;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CASPASE 3; CASPASES; CENTRAL NERVOUS SYSTEM NEOPLASMS; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION; GENE THERAPY; GENETIC VECTORS; GLIOMA; HUMANS; MICE; MICE, NUDE; MUTATION; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS; TELOMERASE; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

MUS MUSCULUS;

EID: 20844439556     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2005.16.685     Document Type: Article

References (45)

1. BOLD, R.J., TERMUHLEN, P.M., and MCCONKEY, D.J. (1997). Apoptosis, cancer and cancer therapy. Surg. Oncol. 6, 133-142.
2. CLAYMAN, G.L., EL-NAGGAR, A.K., LIPPMAN, S.M., HENDERSON, Y.C., FREDERICK, M., MERRITT, J.A., ZUMSTEIN, L.A., TIMMONS, T.M., LIU, T.J., GINSBERG, L., ROTH, J.A., HONG, W.K., BRUSO, P., and GOEPFERT, H. (1998). Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma. J. Clin. Oncol. 16, 2221-2232.
3. DAIDO, S., KANZAWA, T., YAMAMOTO, A., TAKEUCHI, H., KONDO, Y., and KONDO, S. (2004). Pivotal role of the cell death factor BNIP3 in ceramide-induced autophagic cell death in malignant glioma cells. Cancer Res. 64, 4286-4293.
4. DEMASTERS, B.K., MARKHAM, N., LILLEHEI, K.O., and SHROYER, K.R. (1997). Differential telomerase expression in human primary intracranial tumors. Am. J. Clin. Pathol. 107, 548-554.
5. DEWSON, G., SNOWDEN, R.T., ALMOND, J.B., DYER, M.J., and COHEN, G.M. (2003). Conformational change and mitochondrial translocation of Bax accompany proteasome inhibitor-induced apoptosis of chronic lymphocytic leukemic cells. Oncogene 22, 2643-2654.
6. FENG, J., FUNK, W.D., WANG, S.S., WEINRICH, S.L., AVILION, A.A., CHIU, C.P., ADAMS, R.R., CHANG, E., ALLSOPP, R.C., YU, J., LE, S., WEST, M.D., HARLERY, C.B., ANDREWS, W.H., GREIDER, C.W., and VILLEPONTEAU, B. (1995). The RNA component of human telomerase. Science 269, 1236-1241.
7. GOMEZ-MANZANO, C., FUEYO, J., KYRITSIS, A.P., STECK, P.A., ROTH, J.A., MCDONNELL, T.J., STECK, K.D., LEVIN, V.A., and YUNG, W.K. (1996). Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis. Cancer Res. 56, 694-699.
8. GOMEZ-MANZANO, C., FUEYO, J., KYRITSIS, A.P., MCDONNELL, T.J., STECK, P.A., LEVIN, V.A., and YUNG, W.K. (1997). Characterization of p53 and p21 functional interactions in glioma cells en route to apoptosis. J. Natl. Cancer Inst. 89, 1036-1044.
9. HAKIN-SMITH, V., JELLINEK, D.A., LEVY, D., CARROLL, T., TEO, M., TIMPERLEY, W.R., MCKAY. M.J., REDDEL, R.R., and ROYDS, J.A. (2003). Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme. Lancet 361, 836-838.
10. HAN, J., FLEMINGTON, C., HOUGHTON, A.B., GU, Z., ZAMBETTI, G.P., LUTZ, R.J., ZHU, L., and CHITTENDEN, T. (2001). Expression of bbc3, a pro-apoptotic BH3-only gene, is regulated by diverse cell death and survival signals. Proc. Natl. Acad. Sci. U.S.A. 98, 11318-11323.
11. L during apoptosis. Proc. Natl. Acad. Sci. U.S.A. 94, 3668-3672.
12. JEFFERS, J.R., PARGANAS, E., LEE, Y., YANG, C., WANG, J., BRENNAN, J., MACLEAN, K.H., HAN, J., CHITTENDEN, T., IHLE, J.N., MCKINNON, P.J., CLEVELAND, J.L., and ZAMBETTI, G.P. (2003). PUMA is an essential mediator of p53-dependent and -independent apoptotic pathways. Cancer Cell 4, 321-328.
13. JURGENSMEIER, J.M., XIE, Z., DEVERAUX, Q., ELLERBY, L., BREDESEN, D., and REED, J.C. (1998). Bax directly induces release of cytochrome c from isolated mitochondria. Proc. Natl. Acad. Sci. U.S.A. 95, 4997-5002.
14. KANZAWA, T., GERMANO, I.M., KOMATA, T., ITO, H., KONDO, Y., and KONDO, S. (2004). Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death Differ. 11, 448-457.
15. KELEKAR, A., and THOMPSON, C.B. (1998). Bcl-2-family proteins: The role of the BH3 domain in apoptosis. Trends Cell Biol. 8, 324-330.
16. KOGA, S., HIROHATA, S., KONDO, Y., KOMATA, T., TAKAKURA, M., INOUE, M., KYO, S., and KONDO, S. (2000). A novel telomerase-specific gene therapy: Gene transfer of caspase-8 utilizing the human telomerase catalytic subunit gene promoter. Hum. Gene Ther. 11, 1397-1406.
17. KOMATA, T., KONDO, Y., KOGA, S., KO, S.C., CHUNG, L.W., and KONDO, S. (2000). Combination therapy of malignant glioma cells with 2-5A-antisense telomerase RNA and recombinant adenovirus p53. Gene Ther. 7, 2071-2079.
18. KOMATA, T., KONDO, Y., KANZAWA, T., HIROHATA, S., KOGA, S., SUMIYOSHI, H., SRINIVASULA, S.M., BARNA, B.P., GERMANO, I.M., TAKAKURA, M., INOUE, M., ALNEMRI, E.S., SHAY, J.W., KYO, S., and KONDO, S. (2001). Treatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerase catalytic subunit (human telomerase reverse transcriptase) gene promoter. Cancer Res. 61, 5796-5802.
19. KOMATA, T., KONDO, Y., KANZAWA, T., ITO, H., HIROHATA, S., KOGA, S., SUMIYOSHI, H., TAKAKURA, M., INOUE, M., BARNA, B.P., GERMANO, I.M., KYO, S., and KONDO, S. (2002). Caspase-8 gene therapy using the human telomerase reverse transcriptase promoter for malignant glioma cells. Hum. Gene Ther. 13, 1015-1025.
20. KONDO, S., BARNA, B.P., MORIMURA, T., TAKEUCHI, J., YUAN, J., AKBASAK, A., and BARNETT, G.H. (1995). Interleukin-1β-converting enzyme mediates cisplatin-induced apoptosis in malignant glioma cells. Cancer Res. 55, 6166-6171.
21. KONDO, S., TANAKA, Y., KONDO, Y., ISHIZAKA, Y., HITOMI, M., HAQQI, T., LIU, J., BARNETT, G.H., ALNEMRI, E.S., and BARNA, B.P. (1998). Retroviral transfer of CPP32β gene into malignant gliomas in vitro and in vivo. Cancer Res. 58, 962-967.
22. LANG, F.F., YUNG, W.K., SAWAYA, R., and TOFILON, P.J. (1999). Adenovirus-mediated p53 gene therapy for human gliomas. Neurosurgery 45, 1093-1104.
23. LANG, F.F., BRUNER, J.M., FULLER, G.N., ALDAPE, K., PRADOS, M.D., CHANG, S., BERGER, M.S., MCDERMOTT, M.W., KUNWAR, S.M., JUNCK, L.R., CHANDLER, W., ZWIEBEL, J.A., KAPLAN, R.S., and YUNG, W.K. (2003). Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: Biological and clinical results. J. Clin. Oncol. 21, 2508-2518.
24. LANGFORD, L.A., PIATYSZEK, M.A., XU, R., SCHOLD, S.C., Jr., and SHAY, J.W. (1995). Telomerase activity in human brain tumors. Lancet 346, 1267-1268.
25. LE, S., ZHU, J.J., ANTHONY, D.C., GREIDER, C.W., and BLACK, P.M. (1998). Telomerase activity in human gliomas. Neurosurgery 42, 1120-1125.
26. LI, H., ALONSO-VANEGAS, M., COLICOS, M.A., JUNG, S.S., LOCHMULLER, H., SADIKOT, A.F., SNIPES, G.J., SETH, P., KARPATI, G., and NALBANTOGLU, J. (1999). Intracerebral adenovirus-mediated p53 tumor suppressor gene therapy for experimental human glioma. Clin. Cancer Res. 5, 637-642.
27. MELINO, G., BERNASSOLA, F., RANALLI, M., YEE, K., ZONG, W.X., CORAZZARI, M., KNIGHT, R.A., GREEN, D.R., THOMPSON, C., and VOUSDEN, K.H. (2003). p73 induces apoptosis via PUMA transactivation and Bax mitochondrial translocation. J. Biol. Chem. 279, 8076-8083.
28. MEYERSON, M., COUNTER, C.M., EATON, E.N., ELLISEN, L.W., STEINER, P., CADDLE, S.D., ZIAUGRA, L., BEIJERSBERGEN, R.L., DAVIDOFF, M.L., LIU, Q., BACCHETTI, S., HABER, D.A., and WEINBERG, R.A. (1997). hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90, 785-795.
29. NAKAMURA, T.M., MORIN, G.B., CHAPMAN, K.B., WEINRICH, S.L., ANDREWS, W.H., LINGNER, J., HARLEY, C.B., and CECH, T.R. (1997). Telomerase catalytic subunit homologs from fission yeast and human. Science 277, 955-959.
30. NAKANO, K., and VOUSDEN, K.H. (2001). PUMA, a novel proapoptotic gene, is induced by p53. Mol. Cell 7, 683-694.
31. NAKAYAMA, J., TAHARA, H., TAHARA, E., SAITO, M., ITO, K., NAKAMURA, H., NAKANISHI, T., IDE, T., and ISHIKAWA, F. (1998). Telomerase activation by hTR in human normal fibroblasts and hepatocellular carcinomas. Nat. Genet. 18, 65-68.
32. OLTVAI, Z.N., MILLIMAN, C.L., and KORSMEYER, S.J. (1993). Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74, 609-619.
33. RIEGER, L., WELLER, M., BORNEMANN, A., SCHABET, M., DICHGANS, J., and MEYERMANN, R. (1998). BCL-2 family protein expression in human malignant glioma: a clinical-pathological correlative study. J. Neurol. Sci. 155, 68-75.
34. ROSSE, T., OLIVIER, R., MONNEY, L., RAGER, M., CONUS, S., FELLAY, I., JANSEN, B., and BORNER, C. (1998). Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c. Nature 391, 496-499.
35. ROTH, J.A., and CRISTIANO, R.J. (1997). Gene therapy for cancer: What have we done and where are we going? J. Natl. Cancer Inst. 89, 21-39.
36. SHINOURA, N., KOIKE, H., FURITU, T., HASHIMOTO, M., ASAI, A., KIRINO, T., and HAMADA, H. (2000). Adenovirus-mediated transfer of caspase-8 augments cell death in gliomas: Implication for gene therapy. Hum. Gene Ther. 11, 1123-1137.
37. SWISHER, S.G., ROTH, J.A., NEMUNAITIS, J., LAWRENCE, D.D., KEMP, B.L., CARRASCO, C.H., CONNORS, D.G., ELNAGGAR, A.K., FOSSELLA, F., GLISSON, B.S., HONG, W.K., KHURI, F.R., KURIE, J.M., LEE, J.J., LEE, J.S., MACK, M., MERRITT, J.A., NGUYEN, D.M., NESBITT, J.C., PEREZ-SOLER, R., PISTERS, K.M., PUTNAM, J.B., JR., RICHLI, W.R., SAVIN, M., WAUGH, M.K., et al. (1999). Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer. J. Natl. Cancer Inst. 91, 763-771.
38. VILLUNGER, A., MICHALAK, E.M., COULTAS, L., MULLAUER, F., BOCK, G., AUSSERLECHNER, M.J., ADAMS, J.M., and STRASSER, A. (2003). p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science 302, 1036-1038.
39. VOUSDEN, K.H., and LU, X. (2002). Live or let die: The cell's response to p53. Nat. Rev. Cancer 2, 594-604.
40. WEINRICH, S.L., PRUZAN, R., MA, L., OUELLETTE, M., TESMER, V.M., HOLT, S.E., BODNAR, A.G., LICHTSTEINER, S., KIM, N.W., TRAGER, J.B., TAYLOR, R.D., CARLOS, R., ANDREWS, W.H., WRIGHT, W.E., SHAY, J.W., HARLEY, C.B., and MRIN, G.B. (1997). Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTR. Nat. Genet. 17, 498-502.
41. WOLTER, K.G., HSU, Y.T., SMITH, C.L., NECHUSHTAN, A., XI, X.G., and YOULE, R.J. (1997). Movement of Bax from the cytosol to mitochondria during apoptosis. J. Cell Biol. 139, 1281-1292.
42. WYLLIE, A.H., KERR, J.F., and CURRIE, A.R. (1980). Cell death: The significance of apoptosis. Int. Rev. Cytol. 68, 251-306.
43. YU, J., ZHANG, L., HWANG, P.M., KINZLER, K.W., and VOGELSTEIN, B. (2001). PUMA induces the rapid apoptosis of colorectal cancer cells. Mol. Cell 7, 673-682.
44. YU, J., WANG, Z., KINZLER, K.W., VOGELSTEIN, B., and ZHANG, L. (2003). PUMA mediates the apoptotic response to p53 in colorectal cancer cells. Proc. Natl. Acad. Sci. U.S.A. 100, 1931-1936.
45. YU, J.S., SENA-ESTEVES, M., PAULUS, W., BREAKEFIELD, X.O., and REEVES, S.A. (1996). Retroviral delivery and tetracycline-dependent expression of IL-1β-converting enzyme (ICE) in a rat glioma model provides controlled induction of apoptotic death in tumor cells. Cancer Res. 56, 5423-5427.